Abstract Background WHO revised their HIV d
Introduction: Little is known about virologic responses to early antiretroviral therap
Abstract Objective To compare the cost of managing treatment‐limiting cutaneous adverse drug reac
OBJECTIVES: To assess the frequency of and risk factors for discordant responses at 6 months on high
Abstract Objective The Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART)